Accelerating access to precision oncology with decentralized MSK solutions 

SOPHiA GENETICS is collaborating with Memorial Sloan Kettering Cancer Center (MSK) to decentralize their advanced precision oncology tools – MSK-ACCESS® for liquid biopsy and MSK-IMPACT® for comprehensive genomic profiling (CGP). By combining the clinical expertise of MSK in cancer genomics, the predictive algorithms of SOPHiA DDMTM, and the power of the global SOPHiA GENETICS network, experts hope to expand access to precision cancer analysis capabilities worldwide.

Presented by: 

 Michael F. Berger, PhD, Co-Director, Marie-Josée & Henry R. Kravis Center for Molecular Oncology, Elizabeth and Felix Rohatyn Chair for Junior Faculty

Chloe Ryder, Product Manager at SOPHiA GENETICS

Event Date

November 15, 2023 –

Event Type


Event Location

North America

Areas of Interest

Liquid Biopsy, CGP, Oncology

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.